HB 1431: International Drug Reference Pricing
GENERAL BILL by Fine ; Massullo
International Drug Reference Pricing; Requires prescription drug manufacturer permitholders to annually report certain international price data to AHCA; provides for administrative enforcement via specified fine & permit suspension; requires AHCA to contract with entity to designate reference price source countries & establish reference prices for prescription drugs based on certain criteria; requires agency contractor to weigh reference price benchmark value of such countries in two or more tiers, using specified criteria; requires agency contractor to analyze specified data to compare prices among source countries using specified exchange rate source; requires agency contractor to establish reference price for prescribed drugs or products; requires agency contractor to provide reference prices by specified date each year; requires AHCA to publish prices online within specified time; requires pharmacies to charge no more than reference price for cash-paying patients; requires certain health insurers to provide reimbursement for certain prescription drugs no higher than reference price; requires health insurers to use certain savings to offset certain payer costs; requires each health insurer to document anticipated savings & premium reductions in rate filings following availability of reference prices; requires each health insurer to assess actuarial effect of reference pricing program for each insurer product for each plan year; requires each health insurer to submit annual report on assessed effect of such program to OIR or AHCA; requires OIR & AHCA to submit joint report to Governor & Legislature; requires every health maintenance organization to comply with provisions of specified section.
Last Action: 3/8/2024 House - Died in Appropriations Committee
Bill Text: PDF
-
Bill History
Date Chamber Action 1/6/2024 House • Filed
1/9/2024 House • 1st Reading (Original Filed Version)
1/13/2024 House • Referred to Select Committee on Health Innovation
• Referred to Appropriations Committee
• Referred to Health & Human Services Committee
• Now in Select Committee on Health Innovation
1/18/2024 House • Added to Select Committee on Health Innovation agenda
1/22/2024 House • Favorable by Select Committee on Health Innovation
1/23/2024 House • Reported out of Select Committee on Health Innovation
• Now in Appropriations Committee
3/8/2024 House • Died in Appropriations Committee
-
HB 1431, Original Filed Version (Current Bill Version) Posted 1/6/2024 at 5:45 PM
Bill Text: PDF Analyses: Select Committee on Health Innovation (Post-Meeting) 1/23/2024 (pdf)
Related Bills (1)
Bill Number Subject Filed By Relationship Last Action and Location Track Bills S 1750 International Drug Reference Pricing Gruters Similar Last Action: 3/8/2024 S Died in Health Policy 
Citations - Statutes (4)
Citation Catchline Location in Bill Location In Bill Help 465.0244 Information disclosure. Page 6 (pdf) 499.044 Page 3 (pdf) 627.6044 Use of a specific methodology for payment of claims. Page 6 (pdf) 641.30 Construction and relationship to other laws. Page 8 (pdf)